These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31965895)

  • 1. Recent advances in network medicine: From disease mechanisms to new treatment strategies.
    Faria do Valle Í
    Mult Scler; 2020 Apr; 26(5):609-615. PubMed ID: 31965895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inborn errors of metabolism and the human interactome: a systems medicine approach.
    Woidy M; Muntau AC; Gersting SW
    J Inherit Metab Dis; 2018 May; 41(3):285-296. PubMed ID: 29404805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating molecular networks with genetic variant interpretation for precision medicine.
    Capriotti E; Ozturk K; Carter H
    Wiley Interdiscip Rev Syst Biol Med; 2019 May; 11(3):e1443. PubMed ID: 30548534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengths and Opportunities of Network Medicine in Cardiovascular Diseases.
    Benincasa G; Marfella R; Della Mura N; Schiano C; Napoli C
    Circ J; 2020 Jan; 84(2):144-152. PubMed ID: 31866635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches.
    Onisiforou A; Spyrou GM
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Context-enriched interactome powered by proteomics helps the identification of novel regulators of macrophage activation.
    Halu A; Wang JG; Iwata H; Mojcher A; Abib AL; Singh SA; Aikawa M; Sharma A
    Elife; 2018 Oct; 7():. PubMed ID: 30303482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine.
    Turanli B; Karagoz K; Gulfidan G; Sinha R; Mardinoglu A; Arga KY
    Curr Pharm Des; 2018; 24(32):3778-3790. PubMed ID: 30398107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease networks. Uncovering disease-disease relationships through the incomplete interactome.
    Menche J; Sharma A; Kitsak M; Ghiassian SD; Vidal M; Loscalzo J; Barabási AL
    Science; 2015 Feb; 347(6224):1257601. PubMed ID: 25700523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based cancer precision medicine: A new emerging paradigm.
    Tan A; Huang H; Zhang P; Li S
    Cancer Lett; 2019 Aug; 458():39-45. PubMed ID: 31125640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network medicine and type 2 diabetes mellitus: insights into disease mechanism and guide to precision medicine.
    Loscalzo J
    Endocrine; 2019 Dec; 66(3):456-459. PubMed ID: 31410748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing of Molecular Networks for Human Diseases and Drug Discovery.
    Hao T; Wang Q; Zhao L; Wu D; Wang E; Sun J
    Curr Top Med Chem; 2018; 18(12):1007-1014. PubMed ID: 30101711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-Based Disease Module Discovery by a Novel Seed Connector Algorithm with Pathobiological Implications.
    Wang RS; Loscalzo J
    J Mol Biol; 2018 Sep; 430(18 Pt A):2939-2950. PubMed ID: 29791871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network-Based Approaches to Explore Complex Biological Systems towards Network Medicine.
    Fiscon G; Conte F; Farina L; Paci P
    Genes (Basel); 2018 Aug; 9(9):. PubMed ID: 30200360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A paradigm shift in medicine: A comprehensive review of network-based approaches.
    Conte F; Fiscon G; Licursi V; Bizzarri D; D'Antò T; Farina L; Paci P
    Biochim Biophys Acta Gene Regul Mech; 2020 Jun; 1863(6):194416. PubMed ID: 31382052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network medicine: a network-based approach to human disease.
    Barabási AL; Gulbahce N; Loscalzo J
    Nat Rev Genet; 2011 Jan; 12(1):56-68. PubMed ID: 21164525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Interactomics: Comparative Analysis of Different Protein Interaction Resources and Construction of a Cancer Protein-Drug Bipartite Network.
    De Las Rivas J; Alonso-López D; Arroyo MM
    Adv Protein Chem Struct Biol; 2018; 111():263-282. PubMed ID: 29459035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease.
    Ginsberg SD; Neubert TA; Sharma S; Digwal CS; Yan P; Timbus C; Wang T; Chiosis G
    FEBS J; 2022 Apr; 289(8):2047-2066. PubMed ID: 34028172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrative methodology based on protein-protein interaction networks for identification and functional annotation of disease-relevant genes applied to channelopathies.
    Marín M; Esteban FJ; Ramírez-Rodrigo H; Ros E; Sáez-Lara MJ
    BMC Bioinformatics; 2019 Nov; 20(1):565. PubMed ID: 31718537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.